Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection

2016 ◽  
Vol 166 (2) ◽  
pp. 109 ◽  
Author(s):  
Massimo Colombo ◽  
Alessio Aghemo ◽  
Hong Liu ◽  
Jie Zhang ◽  
Hadas Dvory-Sobol ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Kidney Transplant ◽  
Chronic Hepatitis C ◽  
Transplant Recipients ◽  
Genotype 1 ◽  
Kidney Transplant Recipients ◽  
Virus Genotype ◽  
Chronic Hepatitis C Virus

Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection

2019 ◽  
Vol 26 (10) ◽  
pp. 1229-1232
Author(s):  
Tarik Asselah ◽  
Stephen D. Shafran ◽  
Stefan Bourgeois ◽  
Ching‐Lung Lai ◽  
Philippe Mathurin ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Fixed Dose ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Deferred Treatment ◽  
Chronic Hepatitis C Virus ◽  
Dose Combination

scholarly journals Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

Hepatology ◽  
2015 ◽  
Vol 62 (1) ◽  
pp. 25-30 ◽  
Author(s):  
Saleh A. Alqahtani ◽  
Nezam Afdhal ◽  
Stefan Zeuzem ◽  
Stuart C. Gordon ◽  
Alessandra Mangia ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Iii ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Chronic Hepatitis C Virus
Sign in / Sign up

Export Citation Format

Share Document